Balancing Side Effects and Outcomes in Adjuvant Cancer Treatment

In the adjuvant setting, where the goal is to cure patients, it is crucial to ensure that any drugs administered to improve survival do not compromise their quality of life for the following decades. Therefore, it is essential to strike a balance between side effect profile and outcome.

CDK4/6 Inhibitors in Early Stage Breast Cancer

For example, in the case of early stage breast cancer with high-risk hormone receptor positive breast cancer, the addition of CDK4/6 inhibitors to adjuvant care can improve outcomes but may bring more side effects during the two to three year adjuvant treatment period.

Managing Side Effects in Adjuvant Care

To address this issue, it is important to be aware of potential side effects and sometimes even implement prophylactic treatments to improve tolerance to the drug. The lessons learned from managing side effects in the metastatic setting can be applied to improve tolerance in the adjuvant setting as well.

Using Drugs Wisely

The key is to understand how a drug works, its side effect profile, and to balance that with the desired outcome. By doing so, we can make more informed decisions about which drugs to use and how to manage their side effects.